All Stories

  1. Routine Drainage After Pancreaticoduodenectomy

    Article • Annals of Surgery, December 2015, Wolters Kluwer Health

    Mr Nigel B Jamieson

  2. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis

    Article • European Journal of Cancer, July 2015, Elsevier

    Mr Nigel B Jamieson

  3. Outcome after surgical resection for duodenal adenocarcinoma in the UK

    Article • British Journal of Surgery, March 2015, Wiley

    Mr Nigel B Jamieson

  4. Cyst Fluid Biomarkers for Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Critical Review from the International Expert Meeting on Pancreatic Branch-Duct-Intraductal Papillary Mucinous Neoplasms

    Article • Journal of the American College of Surgeons, February 2015, Elsevier

    Mr Nigel B Jamieson

  5. Ligand-Occupied Integrin Internalization Links Nutrient Signaling to Invasive Migration

    Article • Cell Reports, January 2015, Elsevier

    Mr Nigel B Jamieson

  6. Inflammatory Dysregulation and Cancer: From Molecular Mechanisms to Therapeutic Opportunities

    Article • October 2014, Springer Science + Business Media

    Mr Nigel B Jamieson

  7. Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel

    Article • BMC Clinical Pathology, July 2014, Springer Science + Business Media

    Mr Nigel B Jamieson

  8. Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomy

    Article • HPB, July 2014, Elsevier

    Mr Nigel B Jamieson

  9. A meta-analysis of microRNAs with prognostic significance in pancreatic ductal adenocarcinoma

    Article • Pancreatology, June 2014, Elsevier

    Mr Nigel B Jamieson

  10. Sa1937 UK Multicentre Surgical Experience With Primary Duodenal Adenocarcinoma

    Article • Gastroenterology, May 2014, Elsevier

    Mr Nigel B Jamieson

  11. Tu1616 MRI Liver in Pancreatic Cancer: A Game Changer

    Article • Gastroenterology, May 2014, Elsevier

    Mr Nigel B Jamieson

  12. Fascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes

    Article • Gastroenterology, May 2014, Elsevier

    Mr Nigel B Jamieson

  13. Can we move towards personalised pancreatic cancer therapy?

    Article • Expert Review of Gastroenterology & Hepatology, April 2014, Taylor & Francis

    Mr Nigel B Jamieson

  14. A microRNA meta-signature for pancreatic ductal adenocarcinoma

    Article • Expert Review of Molecular Diagnostics, February 2014, Taylor & Francis

    Mr Nigel B Jamieson

  15. Stratified Medicine for Pancreatic Cancer

    Article • January 2014, Elsevier

    Mr Nigel B Jamieson

  16. Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma

    Article • Journal of Gastrointestinal Surgery, February 2013, Springer Science + Business Media

    Mr Nigel B Jamieson

  17. The Prognostic Influence of Resection Margin Clearance Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma

    Article • Journal of Gastrointestinal Surgery, January 2013, Springer Science + Business Media

    Mr Nigel B Jamieson

  18. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

    Article • Pancreatology, January 2013, Elsevier

    Mr Nigel B Jamieson

  19. Molecular pathological phenotypes and outcome in adenocarcinoma of the ampulla of vater

    Article • Pancreatology, January 2013, Elsevier

    Mr Nigel B Jamieson

  20. Abstract B31: The use of mouse models of pancreatic cancer to evaluate sensitivity to targeted therapies.

    Article • Cancer Research, July 2012, American Association for Cancer Research (AACR)

    Mr Nigel B Jamieson

  21. The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

    Article • Annals of Surgical Oncology, May 2012, Springer Science + Business Media

    Mr Nigel B Jamieson

  22. Tumour cox-2 expression correlates with poor prognosis in patients with resectable pancreatic ductal adenocarcinoma

    Article • Pancreatology, May 2012, Elsevier

    Mr Nigel B Jamieson

  23. Loss of e-cadherin and β-catenin expression correlate with poor prognosis in patients with resectable pancreatic ductal adenocarcinoma

    Article • Pancreatology, May 2012, Elsevier

    Mr Nigel B Jamieson

  24. Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression

    Article • Developmental Cell, January 2012, Elsevier

    Mr Nigel B Jamieson

  25. Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma

    Article • Pancreas, November 2011, Wolters Kluwer Health

    Mr Nigel B Jamieson

  26. The Challenges of Improving Survival Following Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma

    Article • Annals of Surgery, August 2011, Wolters Kluwer Health

    Mr Nigel B Jamieson

  27. Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis

    Article • Molecular Cell, April 2011, Elsevier

    Mr Nigel B Jamieson

  28. A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma

    Article • Annals of Surgical Oncology, January 2011, Springer Science + Business Media

    Mr Nigel B Jamieson

  29. Peripancreatic Fat Invasion Is an Independent Predictor of Poor Outcome Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma

    Article • Journal of Gastrointestinal Surgery, November 2010, Springer Science + Business Media

    Mr Nigel B Jamieson

  30. LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest

    Article • Gastroenterology, August 2010, Elsevier

    Mr Nigel B Jamieson

  31. Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma

    Article • Gastroenterology, July 2010, Elsevier

    Mr Nigel B Jamieson

  32. Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma

    Article • Annals of Surgery, June 2010, Wolters Kluwer Health

    Mr Nigel B Jamieson

  33. M1964 A MicroRNA Prognostic Signature for Pancreatic Ductal Adenocarcinoma

    Article • Gastroenterology, May 2010, Elsevier

    Mr Nigel B Jamieson

  34. M1965 Integrative Transcriptomic and Genomic Analysis Reveals Pathways and Networks Underlying Clinicopathological Characteristics of Pancreatic Ductal Adenocarcinoma

    Article • Gastroenterology, May 2010, Elsevier

    Mr Nigel B Jamieson

  35. 802 Peripancreatic Fat Invasion is an Independent Predictor of Poor Outcome Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma and Influences the Pattern of Recurrence

    Article • Gastroenterology, May 2010, Elsevier

    Mr Nigel B Jamieson

  36. W1683 The Prognostic Influence of Lymph Node Ratio Following Pancreaticoduodenectomy for Ampullary Adenocarcinoma

    Article • Gastroenterology, May 2010, Elsevier

    Mr Nigel B Jamieson

  37. Drug induced pancreatitis

    Article • Best Practice & Research Clinical Gastroenterology, April 2010, Elsevier

    Mr Nigel B Jamieson

  38. Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in pe...

    Article • BMC Genomics, January 2010, Springer Science + Business Media

    Mr Nigel B Jamieson, Professor Nicol Keith

  39. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, April 2009, Elsevier

    Mr Nigel B Jamieson, Professor Nicol Keith

  40. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer

    Article • Pancreatology, October 2006, Elsevier

    Mr Nigel B Jamieson

  41. Adiponectin Predicts Insulin Resistance But Not Endothelial Function in Young, Healthy Adolescents

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2005, Endocrine Society

    Mr Nigel B Jamieson

  42. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer

    Article • Cytokine, July 2004, Elsevier

    Mr Nigel B Jamieson